Compound Detail
CHEMBL3545311
BRIGATINIB 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2P(C)(C)=O)n1
Basic Information
| ChEMBL ID | CHEMBL3545311 |
| Name | BRIGATINIB |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | AILRADAXUVEEIR-UHFFFAOYSA-N |
| Therapeutic | ✓ Yes |
93
Targets
349
Activities
2
Assay Types
22
PK Parameters
20
Publications
4
Known Names
5
Indications
2
Mechanisms
Molecular Properties
584.1
MW (Da)
5.09
ALogP
9
HBA
2
HBD
85.9
PSA (Ų)
0.35
QED
2
Ro5 Violations
8
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 2017 |
| Availability | Prescription |
| Chirality | Achiral |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| ALK tyrosine kinase receptor inhibitor | INHIBITOR | ALK tyrosine kinase receptor | ✓ | ✓ |
| Epidermal growth factor receptor erbB1 inhibitor | INHIBITOR | Epidermal growth factor receptor | ✓ | ✓ |
Indications
Carcinoma, Non-Small-Cell Lung Neoplasms Carcinoma Lung Neoplasms Lymphoma, Large-Cell, Anaplastic
ATC Classification
L01ED04
brigatinib
Level 1: ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
Level 2: ANTINEOPLASTIC AGENTS
Activity Summary
IC50 347 meas. best 10.19
EC50 2 meas. best 6.53
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| BaF3 CHEMBL614524 | IC50 | 10.19 | 7.119 | 0.1 | 41 |
| ALK tyrosine kinase receptor CHEMBL4247 | IC50 | 9.43 | 8.616 | 0.4 | 20 |
| Epidermal growth factor receptor CHEMBL203 | IC50 | 9.15 | 7.7004 | 0.7 | 74 |
| Tyrosine-protein kinase Fer CHEMBL3982 | IC50 | 8.89 | 8.89 | 1.3 | 1 |
| A-431 CHEMBL614069 | IC50 | 8.87 | 6.6717 | 1.4 | 6 |
| PC-9 CHEMBL614102 | IC50 | 8.84 | 6.6655 | 1.5 | 11 |
| Receptor-type tyrosine-protein kinase FLT3 CHEMBL1974 | IC50 | 8.82 | 7.4543 | 1.5 | 7 |
| SR CHEMBL614300 | IC50 | 8.72 | 8.59 | 1.9 | 3 |
| Proto-oncogene tyrosine-protein kinase ROS CHEMBL5568 | IC50 | 8.72 | 8.72 | 1.9 | 2 |
| HCC827 CHEMBL4296422 | IC50 | 8.52 | 7.6533 | 3.0 | 3 |
| Tyrosine-protein kinase Fes/Fps CHEMBL5455 | IC50 | 8.46 | 8.46 | 3.5 | 1 |
| Focal adhesion kinase 1 CHEMBL2695 | IC50 | 8.41 | 8.41 | 3.9 | 1 |
| Protein-tyrosine kinase 6 CHEMBL4601 | IC50 | 8.39 | 8.39 | 4.1 | 1 |
| Testis-specific serine/threonine-protein kinase 1 CHEMBL6003 | IC50 | 8.36 | 8.36 | 4.4 | 1 |
| Serine/threonine-protein kinase Chk2 CHEMBL2527 | IC50 | 8.25 | 8.22 | 5.6 | 2 |
| Unchecked CHEMBL612545 | IC50 | 8.25 | 6.7228 | 5.6 | 46 |
| EML4-ALK CHEMBL3883330 | IC50 | 8.05 | 7.3292 | 9.0 | 25 |
| Ribosomal protein S6 kinase alpha-2 CHEMBL3906 | IC50 | 7.89 | 7.89 | 13.0 | 1 |
| Leukocyte tyrosine kinase receptor CHEMBL5627 | IC50 | 7.85 | 7.85 | 14.0 | 1 |
| Protein cereblon/EML4/ALK CHEMBL4296166 | IC50 | 7.85 | 7.85 | 14.0 | 1 |
| ROS1-SDC4 CHEMBL5303568 | IC50 | 7.8 | 7.8 | 16.0 | 1 |
| CD74-ROS1 CHEMBL4680046 | IC50 | 7.75 | 7.75 | 18.0 | 1 |
| Tyrosine-protein kinase Yes CHEMBL2073 | IC50 | 7.72 | 7.72 | 19.0 | 1 |
| Proto-oncogene tyrosine-protein kinase receptor Ret CHEMBL2041 | IC50 | 7.66 | 7.4733 | 22.0 | 3 |
| Dual specificity protein kinase CLK1 CHEMBL4224 | IC50 | 7.64 | 7.64 | 23.0 | 1 |
| Protein-tyrosine kinase 2-beta CHEMBL5469 | IC50 | 7.62 | 7.62 | 24.0 | 1 |
| Insulin-like growth factor 1 receptor CHEMBL1957 | IC50 | 7.6 | 7.19 | 24.9 | 3 |
| Ribosomal protein S6 kinase alpha-3 CHEMBL2345 | IC50 | 7.58 | 7.58 | 26.0 | 1 |
| Receptor tyrosine-protein kinase erbB-4 CHEMBL3009 | IC50 | 7.57 | 7.57 | 27.0 | 1 |
| Calcium/calmodulin-dependent protein kinase type II subunit delta CHEMBL2801 | IC50 | 7.54 | 7.54 | 29.0 | 1 |
| NON-PROTEIN TARGET CHEMBL3879801 | IC50 | 7.54 | 6.52 | 29.0 | 2 |
| Serine/threonine-protein kinase Chk1 CHEMBL4630 | IC50 | 7.52 | 7.52 | 30.0 | 1 |
| Ribosomal protein S6 kinase alpha-1 CHEMBL2553 | IC50 | 7.52 | 7.52 | 30.0 | 1 |
| NCI-H2228 CHEMBL1075536 | IC50 | 7.51 | 7.375 | 31.2 | 2 |
| Fibroblast growth factor receptor 1 CHEMBL3650 | IC50 | 7.39 | 7.14 | 41.0 | 2 |
| Ribosomal protein S6 kinase alpha-6 CHEMBL4924 | IC50 | 7.38 | 7.38 | 42.0 | 1 |
| Receptor tyrosine-protein kinase erbB-2 CHEMBL1824 | IC50 | 7.38 | 7.38 | 42.0 | 1 |
| Insulin receptor-related protein CHEMBL5483 | IC50 | 7.35 | 7.35 | 45.0 | 1 |
| NUAK family SNF1-like kinase 1 CHEMBL5784 | IC50 | 7.33 | 7.33 | 47.0 | 2 |
| Calcium/calmodulin-dependent protein kinase type II subunit gamma CHEMBL3829 | IC50 | 7.32 | 7.32 | 48.0 | 1 |
| Leucine-rich repeat serine/threonine-protein kinase 2 CHEMBL1075104 | IC50 | 7.29 | 7.29 | 51.0 | 1 |
| Tyrosine-protein kinase FRK CHEMBL4223 | IC50 | 7.28 | 7.28 | 52.0 | 1 |
| Vascular endothelial growth factor receptor 3 CHEMBL1955 | IC50 | 7.24 | 7.24 | 58.0 | 1 |
| Hepatocyte growth factor receptor CHEMBL3717 | IC50 | 7.16 | 7.16 | 70.0 | 1 |
| Calcium/calmodulin-dependent protein kinase kinase 2 CHEMBL5284 | IC50 | 7.09 | 7.09 | 82.0 | 1 |
| Mast/stem cell growth factor receptor Kit CHEMBL1936 | IC50 | 7.08 | 6.9167 | 83.0 | 3 |
| MAP kinase-interacting serine/threonine-protein kinase 1 CHEMBL4718 | IC50 | 7.06 | 7.06 | 88.0 | 1 |
| Serine/threonine-protein kinase MARK2 CHEMBL3831 | IC50 | 7.03 | 7.03 | 93.0 | 1 |
| Serine/threonine-protein kinase D3 CHEMBL2595 | IC50 | 7.02 | 7.02 | 95.0 | 1 |
| Phosphorylase b kinase gamma catalytic chain, liver/testis isoform CHEMBL2349 | IC50 | 6.97 | 6.97 | 108.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 2268.0 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 3954.0 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 5772.0 | ng.hr.mL-1 | Mus musculus |
| AUC | 6493.0 | ng.hr.mL-1 | Mus musculus |
| AUC | 6502.0 | ng.hr.mL-1 | Mus musculus |
| AUC | 6493.0 | ng.hr.mL-1 | Mus musculus |
| AUC | 6502.0 | ng.hr.mL-1 | Mus musculus |
| CL | 7.667 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 3.1 | mL.min-1.g-1 | Homo sapiens |
| Cmax | 522.16 | nM | Rattus norvegicus |
| Cmax | 766.98 | nM | Mus musculus |
| Cmax | 1587.03 | nM | Mus musculus |
| Cmax | 1587.03 | nM | Mus musculus |
| F | 52.0 | % | Rattus norvegicus |
| Fu | 0.155 | - | Homo sapiens |
| Fu | 0.343 | - | Homo sapiens |
| T1/2 | 4.8 | hr | Rattus norvegicus |
| T1/2 | 3.4 | hr | Rattus norvegicus |
| T1/2 | 5.8 | hr | Mus musculus |
| T1/2 | 2.8 | hr | Mus musculus |
| T1/2 | 2.8 | hr | Mus musculus |
| Tmax | 4.0 | hr | Rattus norvegicus |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine